Key result
A baseline global longitudinal strain >-12.65% independently predicted 30-day major adverse cardiovascular events in patients with STEMI and preserved LVEF.
Why the study?
Does baseline global longitudinal strain (GLS) predict 30-day adverse clinical outcomes in patients with successfully reperfused STEMI and LVEF ≥ 50%?
Cohort (n=110)
Does baseline global longitudinal strain (GLS) predict 30-day adverse clinical outcomes in patients with successfully reperfused STEMI and LVEF ≥ 50%?
Early calculation of global longitudinal strain can identify high-risk patients for 30-day adverse events among those with preserved LVEF after STEMI.
Answers are grounded in this paper and cite their sources.
May refine post-STEMI risk stratification in preserved LVEF; leaves open prospective validation before clinical use.
BACKGROUND: Left ventricular ejection fraction (LVEF) is fundamental for risk stratification after ST-segment elevation myocardial infarction (STEMI). However, it lacks discrimination power within normal range. Novel echocardiographic deformation parameters may be of benefit for those with post-MI preserved LVEF. OBJECTIVES: We hypothesized that semiautomated calculation of baseline global longitudinal strain (GLS) can identify high-risk group among patients with LVEF ≥ 50% following STEMI. METHODS: During the period from January to July 2017, 110 patients with successful reperfusion of STEMI and LVEF ≥ 50% were prospectively included. Within 48 hours, patients underwent a baseline GLS study with follow-up study at 30 days. The endpoint was a composite of cardiovascular mortality, rehospitalization for heart failure, and urgent revascularization. RESULTS: Mean GLS value changed from -16 ± 4% at baseline to -12 ± 4% at 30-day follow-up (P < .001). At 30 days, cardiovascular mortality was reported in 4.5%, 11.8% were rehospitalized due to heart failure, and 5.4% underwent urgent revascularization. ROC curve analysis showed that a cutoff baseline GLS value >-12.65% predicted 30-day MACEs with a sensitivity and specificity of 77.8% and 83.7%, respectively (AUC 0.784, 95% CI 0.646-0.921, P < .001). An adjusted multivariate logistic regression analysis revealed that baseline GLS value >-12.65% to be the only significant independent predictor for occurrence of MACEs (OR 19.54, 95% CI 6.3-61.1, P < .001). CONCLUSION: Early GLS calculation predicts 30-day outcome in patients with preserved LVEF following reperfusion of STEMI.
No takes yet. Share an insight, caveat, or question.
Bendary et al. (2018) conducted a cohort in ST-segment elevation myocardial infarction with preserved systolic function (n=110). Baseline global longitudinal strain (GLS) >-12.65% vs. Baseline GLS ≤-12.65% was evaluated on Composite of cardiovascular mortality, rehospitalization for heart failure, and urgent revascularization (MACEs) (OR 19.54, 95% CI 6.3-61.1, p=<.001). A baseline global longitudinal strain >-12.65% independently predicted 30-day major adverse cardiovascular events in patients with STEMI and preserved LVEF.
Synapse has enriched 10 related papers. Consider them for comparative context: